<DOC>
	<DOC>NCT00207090</DOC>
	<brief_summary>The purpose of this study is to test how rifampin affects the removal of BMS-247550 (ixabepilone) from the body.</brief_summary>
	<brief_title>Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Up to three prior chemotherapy regimens Measurable or nonmeasurable disease Available for treatment and followup Neuropathy Uncontrolled cardiovascular disease Refusal to participate in genetic analysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>